Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

EDTA: Chemistry and Properties01:22

EDTA: Chemistry and Properties

2.2K
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
2.2K
Complexation Equilibria: The Chelate Effect01:19

Complexation Equilibria: The Chelate Effect

685
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
685
EDTA: Auxiliary Complexing Reagents01:26

EDTA: Auxiliary Complexing Reagents

680
EDTA titrations are usually carried out in highly basic conditions, where the fully deprotonated form of EDTA, Y4−, actively complexes with the free metal ions in the solution. Several metal ions precipitate as hydrous oxide (hydroxides, oxides, or oxyhydroxides) under these conditions, lowering the concentration of free metal ions in the solution. For this reason, auxiliary complexing agents or ligands such as ammonia, tartrate, citrate, or triethanolamine are used in EDTA titrations to...
680
Complexometric Titration: Ligands00:43

Complexometric Titration: Ligands

1.1K
Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...
1.1K
Masking and Demasking Agents01:19

Masking and Demasking Agents

2.7K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
2.7K
Metal-Ligand Bonds02:51

Metal-Ligand Bonds

21.5K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
21.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating Therapeutic Efficacy of SCL7A11 and GLUT1 Inhibition in Triple-Negative Breast Cancer via a GSH/ATP Dual-NIR-Responsive Fluorogenic Sensor.

Analytical chemistry·2026
Same author

Revealing the Interplay of Intraorganellar O<sub>2</sub><sup>•-</sup> and ATP in Brain Aging-Related Alzheimer's Disease via Unimolecular Dual-Responsive Probes.

Analytical chemistry·2025
Same author

Selective Crystallization Separation of Uranium(VI) Complexes from Lanthanides.

Inorganic chemistry·2025
Same author

Photoresponsive Nanoarchitectonics Based on Copper-Porphyrins for Near-Infrared-Enhanced Bacterial Treatment.

ACS omega·2024
Same author

Dual-Channel/Localization Single-Molecule Fluorescence Probe for Monitoring ATP and HOCl in Early Diagnosis and Therapy of Rheumatoid Arthritis.

Analytical chemistry·2024
Same author

Europium- and Black Phosphorus-Functionalized Porphyrin as an l-Arginine Sensor and l-Arginine-Activated PDT/PTT Agent for Bacterial Treatment.

ACS applied materials & interfaces·2023

Related Experiment Video

Updated: Sep 19, 2025

Methods for Analyzing the Impacts of Natural Uranium on In Vitro Osteoclastogenesis
09:51

Methods for Analyzing the Impacts of Natural Uranium on In Vitro Osteoclastogenesis

Published on: January 30, 2018

8.2K

A Tetradentate Chelator for Reducing Damage Caused by Uranium.

Yong Li1, Bin Yang1, Wangbo Qu1

  • 1State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Collaborative Innovation Center of Advanced Microstructures, Nanjing University, Nanjing 210023, P. R. China.

Inorganic Chemistry
|June 16, 2025
PubMed
Summary

A new uranium chelator, MDDO, shows lower toxicity and effectively removes uranium from organs. This development offers a promising approach for mitigating internal damage from nuclear exposure and enhancing nuclear safety.

More Related Videos

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
09:23

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability

Published on: June 21, 2015

9.9K
Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
10:54

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

8.3K

Related Experiment Videos

Last Updated: Sep 19, 2025

Methods for Analyzing the Impacts of Natural Uranium on In Vitro Osteoclastogenesis
09:51

Methods for Analyzing the Impacts of Natural Uranium on In Vitro Osteoclastogenesis

Published on: January 30, 2018

8.2K
Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
09:23

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability

Published on: June 21, 2015

9.9K
Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
10:54

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

8.3K

Area of Science:

  • Nuclear Chemistry
  • Toxicology
  • Radiopharmaceutical Chemistry

Background:

  • The nuclear industry's growth presents challenges in managing radioactive contamination.
  • Uranium, a radionuclide, poses significant risks due to its toxicity and radioactivity.
  • Existing uranium decorporation agents have limitations, including low selectivity and high toxicity.

Purpose of the Study:

  • To synthesize and evaluate a novel tetradentate chelating agent, MDDO, for uranium decorporation.
  • To compare the efficacy and toxicity of MDDO with the current standard treatment, CaNa3-DTPA.
  • To assess the potential of MDDO in mitigating uranium-induced cellular damage and facilitating radionuclide removal in vivo.

Main Methods:

  • Synthesis of the tetradentate chelating agent MDDO.
  • In vitro assessment of MDDO's toxicity and its effect on uranium-induced cellular damage.
  • In vivo studies to determine the efficacy of MDDO in removing uranyl ions from kidneys and femurs.

Main Results:

  • MDDO demonstrated significantly lower toxicity compared to CaNa3-DTPA.
  • MDDO effectively reduced uranium-induced cellular damage.
  • In vivo studies showed MDDO achieved 49.6% uranyl ion removal in kidneys and 52.0% in femurs.

Conclusions:

  • MDDO is a promising chelating agent with reduced toxicity for uranium decorporation.
  • MDDO's efficacy in reducing uranium burden in key organs suggests its potential therapeutic value.
  • These findings support the development of advanced radionuclide decorporation agents for improved nuclear safety and public health.